Experimental autoimmune encephalomyelitis, originally experimental allergic encephalomyelitis, is the well-known animal model of multiple sclerosis, an immune- mediated, demyelinating, inflammatory chronic disease of the central nervous system. The experimental disease is widely utilized to test new therapies in preclinical studies, to investigate new hypothesis on the possible pathogenic mechanisms of autoimmune reaction directed against the central nervous system or more generally to investigate the interactions between the immune system and the central nervous system that lead to neuroinflammation. The experimental autoimmune encephalomyelitis may be induced following different protocols in mammals, including nonhuman primates, and autoreactive CD4+ T-lymphocytes directed against myelin antigens are the main factors. Here, after introducing the model, we describe the protocol to induce active EAE in inbred mice, we report on a table the different clinical courses of EAE depending on the combination of antigen/mouse strain and we provide indications on how to evaluate the clinics and pathology of this induced disease.
CITATION STYLE
Ballerini, C. (2021). Experimental autoimmune encephalomyelitis. In Methods in Molecular Biology (Vol. 2285, pp. 375–384). Humana Press Inc. https://doi.org/10.1007/978-1-0716-1311-5_27
Mendeley helps you to discover research relevant for your work.